Androgen deficiency as a biological determinant of frailty: Hope or hype?

Journal of the American Geriatrics Society

Volumn 62, Issue 6, 2014, Pages 1174-1178

  Afilalo, Jonathan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

androgen; frailty; outcomes; testosterone

Indexed keywords

ANDROGEN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; FRAIL ELDERLY; HUMAN; IMMUNOASSAY; INTERVENTION STUDY; LONGITUDINAL STUDY; MEASUREMENT ERROR; SELECTION BIAS;

ANDROGEN; FRAILTY; OUTCOMES; TESTOSTERONE;

AGED; ANDROGENS; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS;

EID: 84902377670     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12835     Document Type: Article

References (45)

1. Araujo AB, Dixon JM, Suarez EA, et al. Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-Analysis. J Clin Endocrinol Metab 2011; 96: 3007-3019.
2. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-2559.
3. Traish AM, Kang HP, Saad F, et al. Dehydroepiandrosterone (DHEA)-A precursor steroid or an active hormone in human physiology. J Sex Med 2011; 8: 2960-2982; quiz 2983.
4. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-731.
5. Bassil N, Morley JE,. Late-life onset hypogonadism: A review. Clin Geriatr Med 2010; 26: 197-222.
6. Maggio M, Lauretani F, Ceda GP, et al. Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc 2006; 54: 1832-1838.
7. Maggio M, Basaria S, Ceda GP, et al. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 2005; 28: 116-119.
8. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341.
9. Barzilay JI, Blaum C, Moore T, et al. Insulin resistance and inflammation as precursors of frailty: The Cardiovascular Health Study. Arch Intern Med 2007; 167: 635-641.
10. Eichholzer M, Barbir A, Basaria S, et al. Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male 2012; 15: 208-215.
11. Mohr BA, Bhasin S, Kupelian V, et al. Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc 2007; 55: 548-555.
12. van den Beld A, Huhtaniemi IT, Pettersson KS, et al. Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab 1999; 84: 1334-1339.
13. Schaap LA, Pluijm SMF, Smit JH, et al. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol 2005; 63: 152-160.
14. Wu I-C, Lin X-Z, Liu P-F, et al. Low serum testosterone and frailty in older men and women. Maturitas 2010; 67: 348-352.
15. Cappola AR, Xue Q-L, Fried LP,. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: The Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 2009; 64A: 243-248.
16. Carcaillon L, Blanco C, Alonso-Bouzõn C, et al. Sex differences in the association between serum levels of testosterone and frailty in an elderly population: The Toledo Study for Healthy Aging. PLoS One 2012; 7: e32401.
17. Krasnoff JB, Basaria S, Pencina MJ, et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: The Framingham Offspring Study. J Clin Endocrinol Metab 2010; 95: 2790-2799.
18. Schaap LA, Pluijm SMF, Deeg DJH, et al. Low testosterone levels and decline in physical performance and muscle strength in older men: Findings from two prospective cohort studies. Clin Endocrinol 2008; 68: 42-50.
19. Travison TG, Nguyen A-H, Naganathan V, et al. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: The Concord Health and Ageing in Men Project. J Clin Endocrinol Metab 2011; 96: 2464-2474.
20. Cawthon PM, Ensrud KE, Laughlin GA, et al. Sex hormones and frailty in older men: The Osteoporotic Fractures in Men (MrOS) Study. J Clin Endocrinol Metab 2009; 94: 3806-3815.
21. LeBlanc ES, Wang PY, Lee CG, et al. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab 2011; 96: 3855-3863.
22. Hyde Z, Flicker L, Almeida OP, et al. Low free testosterone predicts frailty in older men: The Health in Men Study. J Clin Endocrinol Metab 2010; 95: 3165-3172.
23. Tajar A, O'Connell MDL, Mitnitski AB, et al. Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: Results from the European Male Aging Study. J Am Geriatr Soc 2011; 59: 814-821.
24. Baylis D, Bartlett DB, Syddall HE, et al. Immune-endocrine biomarkers as predictors of frailty and mortality: A 10-year longitudinal study in community-dwelling older people. Age (Dordr) 2013; 35: 963-971.
25. Boxer RS, Dauser DA, Walsh SJ, et al. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008; 56: 454-461.
26. Maggio M, Lauretani F, Ceda GP, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: The Aging in the Chianti Area (InCHIANTI) Study. Arch Intern Med 2007; 167: 2249-2254.
27. Jankowska EA, Biel B, Majda J, et al. Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival. Circulation 2006; 114: 1829-1837.
28. Vermeulen A, Verdonck L, Kaufman J-M,. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
29. O'Connell MDL, Roberts SA, Srinivas-Shankar U, et al. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J Clin Endocrinol Metab 2011; 96: 454-458.
30. Mauras N, Hayes V, Welch S, et al. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998; 83: 1886-1892.
31. Bylow K, Mohile SG, Stadler WM, et al. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer? A conceptual review. Cancer 2007; 110: 2604-2613.
32. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, et al. Androgen treatment and muscle strength in elderly men: A meta-Analysis. J Am Geriatr Soc 2006; 54: 1666-1673.
33. Caminiti G, Volterrani M, Iellamo F, et al. Effect of long-Acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009; 54: 919-927.
34. Toma M, McAlister FA, Coglianese EE, et al. Testosterone supplementation in heart failure: A meta-Analysis. Circ Heart Fail 2012; 5: 315-321.
35. Kenny AM, Kleppinger A, Annis K, et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc 2010; 58: 1134-1143.
36. Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: A randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010; 95: 639-650.
37. O'Donnell AB, Travison TG, Harris SS, et al. Testosterone, dehydroepiandrosterone, and physical performance in older men: Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2006; 91: 425-431.
38. Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013; 369: 1011-1022.
39. Kenny AM, Boxer RS, Kleppinger A, et al. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc 2010; 58: 1707-1714.
40. Maggio M, Nicolini F, Cattabiani C, et al. Effects of testosterone supplementation on clinical and rehabilitative outcomes in older men undergoing on-pump CABG. Contemp Clin Trials 2012; 33: 730-738.
41. Iannuzzi-Sucich M, Prestwood KM, Kenny AM,. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002; 57A: M772-M777.
42. Szulc P, Duboeuf F, Marchand F, et al. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: The MINOS study. Am J Clin Nutr 2004; 80: 496-503.
43. Baumgartner RN, Waters DL, Gallagher D, et al. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999; 107: 123-136.
44. Roy TA, Blackman MR, Harman SM, et al. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002; 283: E284-E294.
45. Travison TG, Basaria S, Storer TW, et al. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci 2011; 66A: 1090-1099.